Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation.

Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation.

Item

http://www.wikidata.org/entity/Q34430039

Q34430039

about

Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity HDLG5/KIAA0583, encoding a MAGUK-family protein, is a primary progesterone target gene in breast cancer cells Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51 E-cadherin-catenin cell-cell adhesion complex and human cancer Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.Bunched, the Drosophila homolog of the mammalian tumor suppressor TSC-22, promotes cellular growth.Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5.Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids.Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression.Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA.Tetratricopeptide repeat cochaperones in steroid receptor complexes Functional specificity of co-chaperone interactions with Hsp90 client proteins.The Drosophila homolog of human tumor suppressor TSC-22 promotes cellular growth, proliferation, and survival Overexpression of TSC-22 (transforming growth factor- β-stimulated clone-22) causes marked obesity, splenic abnormality and B cell lymphoma in transgenic mice A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2.Effect of geldanamycin on androgen receptor function and stability.Role of TSC-22 during early embryogenesis in Xenopus laevis.Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation.Androgens induce CD-9 in human prostate tissue.Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line.Opposing effects on TSC-22 expression by BMP and receptor tyrosine kinase signals in the developing feather tract.Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.Progesterone prevents radiation-induced apoptosis in breast cancer cells.Null mutation of peroxisome proliferator-activated receptor-interacting protein in mammary glands causes defective mammopoiesis.Bone morphogenetic proteins and retinoic acid induce human endogenous retrovirus HERV-K expression in NT2D1 human embryonal carcinoma cells.Expression of TGF-beta stimulated clone-22 (TSC-22) in mouse development and TGF-beta signalling.

P2860

Q21195170-63D3A4E6-4367-42FB-99F2-562BA60F2D65 Q22010386-674276A1-967D-454F-9189-D01A87F836EA Q24307837-9691FE26-A386-4370-9C24-9C136FE8D7A0 Q24599856-3B07250E-1A28-4486-87A6-C8DF505F2448 Q24671974-AAFC43CF-DBC0-455E-ADB8-C8B130070FBB Q26785555-028FAFC9-03A2-4800-A858-47E4F3E0EA7C Q28142886-4C68FC6C-892E-404D-A3BA-80B3FD753FB2 Q30578094-045C3450-9B3F-4EC0-9344-D2C3AA3120CF Q33316853-3004635D-0D65-480C-B59B-F0142407C971 Q33631526-BB34033A-D5A5-46FC-81ED-CD748590C96A Q33637475-F0904792-3F06-4529-B370-A503BA68B084 Q33716837-26391358-83BB-4F97-B9FC-10D6C9ACA9EC Q33877550-A377B661-7445-4DF6-9BA0-B2BDDA752DCB Q35791463-B09F7D14-5175-40A3-A645-36DD28C28DBC Q35924587-C59AA140-459F-4342-A4F5-E942FE0D29C8 Q36069359-99F094E3-88F5-4543-880C-4674E7D4C1AF Q36535546-8E92BFCB-9A69-4384-8A2B-32547DF2E2F5 Q37046611-87F1E60E-A69B-4D77-A59F-64C326D02E32 Q37106835-4F668584-9363-4959-97F0-B79C79FB3C05 Q37489908-E2E48188-022A-4460-8239-6FADBB4B412F Q38332856-C3A6B262-905A-466C-BB13-0A6053B6F59F Q39491094-47548FA6-9FCB-4178-B017-1082FC0D2EB9 Q40114088-ACFA2DFE-D284-40EB-9878-29B96A9BA40F Q40380360-D80D7843-709E-4754-8B3A-EF8CFBEC6A07 Q40679032-2D795065-F78B-4E7A-A8DE-A2176355CF09 Q40870162-E30376A7-BE4C-4B09-B1C9-29CF4117A21C Q43861929-AF43EFF7-FD13-4C07-ABE9-4AEE99AC54E8 Q44412169-71BA884C-0268-4723-AE28-E3B775E60A68 Q44830455-5E733256-0608-4F63-8AE9-FCD05BB52E60 Q47432371-7873A63F-BB7B-49E7-9D0F-94D7FDD8C65F Q52165591-87DD43AA-8919-4298-BF72-460CE4271C1F Q52166628-3E57F64D-C0C2-4F25-A4A1-3C7C8FDB2F2F

P2860

Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation.

Item

http://www.wikidata.org/entity/Q34430039

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu